Mark Munch - 15 Dec 2021 Form 4 Insider Report for BRUKER CORP (BRKR)

Role: Exec VP&Pres Bruker Nano Inc.
Signature: Sara Hussain, Attorney-in-Fact
Issuer symbol: BRKR
Transactions as of: 15 Dec 2021
Net transactions value: -$1,265,266
Form type: 4
Filing time: 16 Dec 2021, 15:16:21 UTC
Previous filing: 11 Aug 2021
Next filing: 09 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BRKR	Common Stock	Options Exercise	$420,382	+21,210	+25%	$19.82	106,274	15 Dec 2021	Direct
transaction	BRKR	Common Stock	Sale	$1,685,648	-21,210	-20%	$79.47	85,064	15 Dec 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRKR	Stock Option (Right to Purchase)	Options Exercise	$0	-21,210	-100%	$0.000000^*	0	15 Dec 2021	Common Stock	21,210	$19.82	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.60 to $80.54, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.60 to $80.54, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.